Anisha Shridhar
Partner
DelhiPractice Area
Sectors
At this time of significant turbulence in the business world, I am determined to help our clients embrace change, achieve growth and expansion and keep on top of complicated and ever-changing regulatory frameworks.
Anisha Shridhar has 13 years of experience and specialises in Mergers & Acquisitions, Joint Ventures, Private Equity transactions and General Corporate. She also supports the Firm’s Private Client Practice and advises HNIs on the structuring and implementation of succession planning. Anisha regularly advises domestic and international multinational companies and PE funds on a wide range of matters, including foreign exchange, securities, corporate and commercial laws. Her clients span the insurance, telecommunications, financial services, e–commerce and healthcare sectors. Anisha holds an LL.M. degree from Kings College.
WORK HIGHLIGHTS
-
On its ongoing demerger of domestic wiring harness followed by a merger with its promoter entity, pursuant to a composite scheme of arrangement to be approved by NCLT, Mumbai Bench
-
On the USD 1 billion investment by Softbank and other investors in OYO and its subsidiaries
-
On (i) The sale of a majority stake in Max Healthcare Institute Limited to KKR, including through a composite scheme of arrangement sanctioned by the Mumbai NCLT, and subsequent exit of the Max Group from the healthcare business in a USD 1.7 billion deal (ii) The share swap transaction of 21.87% stake held by Mitsui Sumitomo Insurance Company Limited in Max Life Insurance Company Limited, with 20.57% stake in Max Financial Services Limited, a listed company (iii) The joint venture with Axis Bank Limited (iv) The sale of Max India’s 51% stake in Max Bupa to True North, for USD 72 million
-
On (i) The internal restructuring of Max India Limited, awarded the ‘Deal of the Year’ by the Indian Business Law Journal (2016) (ii) Its purchase of a majority stake in Parksons Packaging Limited
-
On its ongoing demerger of domestic wiring harness followed by a merger with its promoter entity, pursuant to a composite scheme of arrangement to be approved by NCLT, Mumbai Bench
-
On the USD 1 billion investment by Softbank and other investors in OYO and its subsidiaries
-
On (i) The sale of a majority stake in Max Healthcare Institute Limited to KKR, including through a composite scheme of arrangement sanctioned by the Mumbai NCLT, and subsequent exit of the Max Group from the healthcare business in a USD 1.7 billion deal (ii) The share swap transaction of 21.87% stake held by Mitsui Sumitomo Insurance Company Limited in Max Life Insurance Company Limited, with 20.57% stake in Max Financial Services Limited, a listed company (iii) The joint venture with Axis Bank Limited (iv) The sale of Max India’s 51% stake in Max Bupa to True North, for USD 72 million
-
On (i) The internal restructuring of Max India Limited, awarded the ‘Deal of the Year’ by the Indian Business Law Journal (2016) (ii) Its purchase of a majority stake in Parksons Packaging Limited
-
On its ongoing demerger of domestic wiring harness followed by a merger with its promoter entity, pursuant to a composite scheme of arrangement to be approved by NCLT, Mumbai Bench
-
On the USD 1 billion investment by Softbank and other investors in OYO and its subsidiaries
-
On (i) The sale of a majority stake in Max Healthcare Institute Limited to KKR, including through a composite scheme of arrangement sanctioned by the Mumbai NCLT, and subsequent exit of the Max Group from the healthcare business in a USD 1.7 billion deal (ii) The share swap transaction of 21.87% stake held by Mitsui Sumitomo Insurance Company Limited in Max Life Insurance Company Limited, with 20.57% stake in Max Financial Services Limited, a listed company (iii) The joint venture with Axis Bank Limited (iv) The sale of Max India’s 51% stake in Max Bupa to True North, for USD 72 million
-
On (i) The internal restructuring of Max India Limited, awarded the ‘Deal of the Year’ by the Indian Business Law Journal (2016) (ii) Its purchase of a majority stake in Parksons Packaging Limited
-
On its ongoing demerger of domestic wiring harness followed by a merger with its promoter entity, pursuant to a composite scheme of arrangement to be approved by NCLT, Mumbai Bench
-
On the USD 1 billion investment by Softbank and other investors in OYO and its subsidiaries
-
On (i) The sale of a majority stake in Max Healthcare Institute Limited to KKR, including through a composite scheme of arrangement sanctioned by the Mumbai NCLT, and subsequent exit of the Max Group from the healthcare business in a USD 1.7 billion deal (ii) The share swap transaction of 21.87% stake held by Mitsui Sumitomo Insurance Company Limited in Max Life Insurance Company Limited, with 20.57% stake in Max Financial Services Limited, a listed company (iii) The joint venture with Axis Bank Limited (iv) The sale of Max India’s 51% stake in Max Bupa to True North, for USD 72 million
-
On (i) The internal restructuring of Max India Limited, awarded the ‘Deal of the Year’ by the Indian Business Law Journal (2016) (ii) Its purchase of a majority stake in Parksons Packaging Limited
-
On its ongoing demerger of domestic wiring harness followed by a merger with its promoter entity, pursuant to a composite scheme of arrangement to be approved by NCLT, Mumbai Bench
-
On the USD 1 billion investment by Softbank and other investors in OYO and its subsidiaries
-
On (i) The sale of a majority stake in Max Healthcare Institute Limited to KKR, including through a composite scheme of arrangement sanctioned by the Mumbai NCLT, and subsequent exit of the Max Group from the healthcare business in a USD 1.7 billion deal (ii) The share swap transaction of 21.87% stake held by Mitsui Sumitomo Insurance Company Limited in Max Life Insurance Company Limited, with 20.57% stake in Max Financial Services Limited, a listed company (iii) The joint venture with Axis Bank Limited (iv) The sale of Max India’s 51% stake in Max Bupa to True North, for USD 72 million
-
On (i) The internal restructuring of Max India Limited, awarded the ‘Deal of the Year’ by the Indian Business Law Journal (2016) (ii) Its purchase of a majority stake in Parksons Packaging Limited
-
On its ongoing demerger of domestic wiring harness followed by a merger with its promoter entity, pursuant to a composite scheme of arrangement to be approved by NCLT, Mumbai Bench
-
On the USD 1 billion investment by Softbank and other investors in OYO and its subsidiaries
-
On (i) The sale of a majority stake in Max Healthcare Institute Limited to KKR, including through a composite scheme of arrangement sanctioned by the Mumbai NCLT, and subsequent exit of the Max Group from the healthcare business in a USD 1.7 billion deal (ii) The share swap transaction of 21.87% stake held by Mitsui Sumitomo Insurance Company Limited in Max Life Insurance Company Limited, with 20.57% stake in Max Financial Services Limited, a listed company (iii) The joint venture with Axis Bank Limited (iv) The sale of Max India’s 51% stake in Max Bupa to True North, for USD 72 million
-
On (i) The internal restructuring of Max India Limited, awarded the ‘Deal of the Year’ by the Indian Business Law Journal (2016) (ii) Its purchase of a majority stake in Parksons Packaging Limited
-
On its ongoing demerger of domestic wiring harness followed by a merger with its promoter entity, pursuant to a composite scheme of arrangement to be approved by NCLT, Mumbai Bench
-
On the USD 1 billion investment by Softbank and other investors in OYO and its subsidiaries
-
On (i) The sale of a majority stake in Max Healthcare Institute Limited to KKR, including through a composite scheme of arrangement sanctioned by the Mumbai NCLT, and subsequent exit of the Max Group from the healthcare business in a USD 1.7 billion deal (ii) The share swap transaction of 21.87% stake held by Mitsui Sumitomo Insurance Company Limited in Max Life Insurance Company Limited, with 20.57% stake in Max Financial Services Limited, a listed company (iii) The joint venture with Axis Bank Limited (iv) The sale of Max India’s 51% stake in Max Bupa to True North, for USD 72 million
-
On (i) The internal restructuring of Max India Limited, awarded the ‘Deal of the Year’ by the Indian Business Law Journal (2016) (ii) Its purchase of a majority stake in Parksons Packaging Limited
-
On its ongoing demerger of domestic wiring harness followed by a merger with its promoter entity, pursuant to a composite scheme of arrangement to be approved by NCLT, Mumbai Bench
-
On the USD 1 billion investment by Softbank and other investors in OYO and its subsidiaries
-
On (i) The sale of a majority stake in Max Healthcare Institute Limited to KKR, including through a composite scheme of arrangement sanctioned by the Mumbai NCLT, and subsequent exit of the Max Group from the healthcare business in a USD 1.7 billion deal (ii) The share swap transaction of 21.87% stake held by Mitsui Sumitomo Insurance Company Limited in Max Life Insurance Company Limited, with 20.57% stake in Max Financial Services Limited, a listed company (iii) The joint venture with Axis Bank Limited (iv) The sale of Max India’s 51% stake in Max Bupa to True North, for USD 72 million
-
On (i) The internal restructuring of Max India Limited, awarded the ‘Deal of the Year’ by the Indian Business Law Journal (2016) (ii) Its purchase of a majority stake in Parksons Packaging Limited
-
On its ongoing demerger of domestic wiring harness followed by a merger with its promoter entity, pursuant to a composite scheme of arrangement to be approved by NCLT, Mumbai Bench
-
On the USD 1 billion investment by Softbank and other investors in OYO and its subsidiaries
-
On (i) The sale of a majority stake in Max Healthcare Institute Limited to KKR, including through a composite scheme of arrangement sanctioned by the Mumbai NCLT, and subsequent exit of the Max Group from the healthcare business in a USD 1.7 billion deal (ii) The share swap transaction of 21.87% stake held by Mitsui Sumitomo Insurance Company Limited in Max Life Insurance Company Limited, with 20.57% stake in Max Financial Services Limited, a listed company (iii) The joint venture with Axis Bank Limited (iv) The sale of Max India’s 51% stake in Max Bupa to True North, for USD 72 million
-
On (i) The internal restructuring of Max India Limited, awarded the ‘Deal of the Year’ by the Indian Business Law Journal (2016) (ii) Its purchase of a majority stake in Parksons Packaging Limited
-
On its ongoing demerger of domestic wiring harness followed by a merger with its promoter entity, pursuant to a composite scheme of arrangement to be approved by NCLT, Mumbai Bench
-
On the USD 1 billion investment by Softbank and other investors in OYO and its subsidiaries
-
On (i) The sale of a majority stake in Max Healthcare Institute Limited to KKR, including through a composite scheme of arrangement sanctioned by the Mumbai NCLT, and subsequent exit of the Max Group from the healthcare business in a USD 1.7 billion deal (ii) The share swap transaction of 21.87% stake held by Mitsui Sumitomo Insurance Company Limited in Max Life Insurance Company Limited, with 20.57% stake in Max Financial Services Limited, a listed company (iii) The joint venture with Axis Bank Limited (iv) The sale of Max India’s 51% stake in Max Bupa to True North, for USD 72 million
-
On (i) The internal restructuring of Max India Limited, awarded the ‘Deal of the Year’ by the Indian Business Law Journal (2016) (ii) Its purchase of a majority stake in Parksons Packaging Limited
-
On its ongoing demerger of domestic wiring harness followed by a merger with its promoter entity, pursuant to a composite scheme of arrangement to be approved by NCLT, Mumbai Bench
-
On the USD 1 billion investment by Softbank and other investors in OYO and its subsidiaries
-
On (i) The sale of a majority stake in Max Healthcare Institute Limited to KKR, including through a composite scheme of arrangement sanctioned by the Mumbai NCLT, and subsequent exit of the Max Group from the healthcare business in a USD 1.7 billion deal (ii) The share swap transaction of 21.87% stake held by Mitsui Sumitomo Insurance Company Limited in Max Life Insurance Company Limited, with 20.57% stake in Max Financial Services Limited, a listed company (iii) The joint venture with Axis Bank Limited (iv) The sale of Max India’s 51% stake in Max Bupa to True North, for USD 72 million
-
On (i) The internal restructuring of Max India Limited, awarded the ‘Deal of the Year’ by the Indian Business Law Journal (2016) (ii) Its purchase of a majority stake in Parksons Packaging Limited
RECENT RECOGNITION
2024
2023
2022
2021
Asialaw Profiles
‘Rising Star’ for Corporate / M&A
IFLR1000
‘Notable Practitioner’ for Corporate and M&A
Asialaw Profiles
‘Rising Star’ for Corporate / M&A
IFLR1000
‘Notable Practitioner’ for Corporate and M&A
Asialaw Profiles
‘Rising Star’ for Corporate / M&A
IFLR1000
‘Notable Practitioner’ for Corporate and M&A
IFLR1000
‘Notable Practitioner’ for Corporate and M&A
RECENT RECOGNITION
Asialaw Profiles
‘Rising Star’ for Corporate / M&A
IFLR1000
‘Notable Practitioner’ for Corporate and M&A
Asialaw Profiles
‘Rising Star’ for Corporate / M&A
IFLR1000
‘Notable Practitioner’ for Corporate and M&A
Asialaw Profiles
‘Rising Star’ for Corporate / M&A
IFLR1000
‘Notable Practitioner’ for Corporate and M&A
IFLR1000
‘Notable Practitioner’ for Corporate and M&A